UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049935
Receipt number R000056874
Scientific Title Prospective cohort study of chronic constipation practice
Date of disclosure of the study information 2022/12/28
Last modified on 2022/12/28 13:09:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective cohort study of chronic constipation practice

Acronym

Prospective cohort study of chronic constipation practice

Scientific Title

Prospective cohort study of chronic constipation practice

Scientific Title:Acronym

Prospective cohort study of chronic constipation practice

Region

Japan


Condition

Condition

constipated person

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyse the therapeutic effect and background factors of the treatment of constipation in patients with constipation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy and safety after starting or changing constipation medication

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. constipation
2. patients with constipation symptoms defined in the Chronic Constipation Guideline as "the inability to expel faeces comfortably and in sufficient quantity". 3. outpatients attending Keio University Hospital and National Hospital Organization Kurihama Medical Centre.
3. outpatients attending Keio University Hospital or National Hospital Organisation Kurihama Medical Centre. 4. patients over 18 years of age at the time of consent.
4. patients who are 18 years of age or older at the time the consent form is obtained. 5. patients whose consent for this study has been obtained.
5. patients whose consent for this study has been obtained.

Key exclusion criteria

1. patients with organic disease as a possible cause of constipation symptoms.
2. other patients who are deemed inappropriate for inclusion in the study by the physician in charge or others.

Target sample size

1600


Research contact person

Name of lead principal investigator

1st name Takanori
Middle name
Last name Kanai

Organization

Keio University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

16008582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Email

takagast@keio.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Mori

Organization

Keio University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

0333531211

Homepage URL


Email

mori-d@keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

0333531211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 12 Month 27 Day

Date of IRB

2022 Year 12 Month 27 Day

Anticipated trial start date

2022 Year 12 Month 28 Day

Last follow-up date

2030 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

During the study period, subjects will visit the hospital as described in section 6 Research methods, and necessary observations will be carried out at each prescribed visit. The following information will be collected during observations and examinations.


Management information

Registered date

2022 Year 12 Month 28 Day

Last modified on

2022 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056874


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name